Free Trial

Sumitomo Mitsui Trust Group Inc. Sells 131,549 Shares of Molina Healthcare, Inc $MOH

Molina Healthcare logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Sumitomo Mitsui Trust Group trimmed its Molina Healthcare stake by 87.2% in Q4, selling 131,549 shares and leaving 19,239 shares valued at about $3.34 million per its latest 13F.
  • Earnings surprise: Molina reported Q EPS of -$2.75 (vs. $0.43 expected) while revenue rose to $11.38 billion, and the company set FY2026 guidance of $5.00 EPS.
  • Analyst outlook is mixed-to-cautious: consensus rating is "Hold" with a $169.21 target after several price-target cuts (e.g., Goldman $124, Mizuho $180) and a spread of 2 Buy / 9 Hold / 2 Sell ratings.
  • Interested in Molina Healthcare? Here are five stocks we like better.

Sumitomo Mitsui Trust Group Inc. decreased its holdings in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 87.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 19,239 shares of the company's stock after selling 131,549 shares during the period. Sumitomo Mitsui Trust Group Inc.'s holdings in Molina Healthcare were worth $3,339,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. New York State Common Retirement Fund boosted its stake in Molina Healthcare by 35.9% during the third quarter. New York State Common Retirement Fund now owns 139,557 shares of the company's stock valued at $26,706,000 after buying an additional 36,831 shares during the period. CenterBook Partners LP boosted its stake in Molina Healthcare by 359.7% during the third quarter. CenterBook Partners LP now owns 20,409 shares of the company's stock valued at $3,905,000 after buying an additional 15,969 shares during the period. Merit Financial Group LLC boosted its stake in Molina Healthcare by 289.3% during the third quarter. Merit Financial Group LLC now owns 11,735 shares of the company's stock valued at $2,246,000 after buying an additional 8,721 shares during the period. Gibraltar Capital Management Inc. bought a new stake in Molina Healthcare during the third quarter valued at $6,709,000. Finally, Cerity Partners LLC boosted its stake in Molina Healthcare by 245.3% during the third quarter. Cerity Partners LLC now owns 80,608 shares of the company's stock valued at $15,425,000 after buying an additional 57,266 shares during the period. Institutional investors own 98.50% of the company's stock.

Analyst Upgrades and Downgrades

MOH has been the subject of several research analyst reports. The Goldman Sachs Group dropped their price target on Molina Healthcare from $167.00 to $124.00 and set a "neutral" rating for the company in a research note on Wednesday, February 11th. UBS Group set a $173.00 price target on Molina Healthcare in a research note on Friday, March 13th. Mizuho dropped their price target on Molina Healthcare from $220.00 to $180.00 and set an "outperform" rating for the company in a research note on Thursday, March 12th. Wall Street Zen raised Molina Healthcare from a "strong sell" rating to a "sell" rating in a research note on Sunday. Finally, TD Cowen dropped their price target on Molina Healthcare from $175.00 to $144.00 and set a "hold" rating for the company in a research note on Monday, February 9th. Two analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $169.21.

View Our Latest Stock Analysis on Molina Healthcare

Molina Healthcare Trading Down 0.2%

Shares of MOH stock opened at $148.58 on Friday. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.97. The business has a 50-day moving average price of $142.57 and a two-hundred day moving average price of $160.30. Molina Healthcare, Inc has a 12-month low of $121.06 and a 12-month high of $333.22. The firm has a market cap of $7.74 billion, a P/E ratio of 17.36 and a beta of 0.55.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing the consensus estimate of $0.43 by ($3.18). The company had revenue of $11.38 billion during the quarter, compared to analysts' expectations of $10.90 billion. Molina Healthcare had a return on equity of 13.60% and a net margin of 1.04%.The firm's quarterly revenue was up 8.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.05 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Equities analysts anticipate that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

Featured Articles

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH - Free Report).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines